Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Wednesday, July 7, 2021

Neonatal syringocystadenoma papilliferum: A case report

paythelady.612 shared this article with you from Inoreader

World J Clin Cases. 2021 Jun 26;9(18):4772-4777. doi: 10.12998/wjcc.v9.i18.4772.

ABSTRACT

BACKGROUND: Syringocystadenoma papilliferum (SCAP) represents a rare, noncancerous adnexal tumor predominantly presenting at birth or in early childhood.

CASE SUMMARY: In this study, a 35-day-old girl was admitted to Kunming Children's Hospital in October 2019 due to a lesion in the right frontotemporal region since birth. The surface of the lesion was bright red, granular, and papillary and easily bled upon touch, with about 1.5 cm × 4 cm in size. A subcutaneous mass was felt at the base of the lesion, with a size of about 3 cm × 5 cm. Dermatoscopy showed that the skin lesion was lobular and crumby. The lesion center was reddish or white, while the edges were white or yellowish band-like. There were polymorphic vascular structures and white radial streaks in the lesion, with some vascular clusters scattered. Pathological examination showe d papilloma-like hyperplasia of the epidermis, with the epidermis partly sinking into the dermis to form several cystic depressions. Combining clinical and histopathological features, the child was diagnosed with SCAP. Follow-up is ongoing, and surgical resection will be performed.

CONCLUSION: This was a special clinical manifestation of SCAP, which complements the clinical manifestations of the disease and provides new insights for the diagnosis and differentiation of neonatal skin tumors.

PMID:34222446 | PMC:PMC8223827 | DOI:10.12998/wjcc.v9.i18.4772

View on the web

No comments:

Post a Comment